An update from ClearPoint Neuro ( ($CLPT) ) is now available. On December 29, 2025, ClearPoint Neuro entered into a consent agreement with CALW SA ...

Minot Light Capital Partners, an investment management company, released its Q3 2025 investment letter. A copy of the letter ...

Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation SOLANA BEACH, CALIFORNIA / ACCESS Newswire ...

[Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of securities laws. These forward-looking statements may include, without limitation, ...

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System.

Shares of UniQure N.V. rose 248% on Wednesday, lifted by a successful trial of the biotech’s gene therapy for Huntington’s disease, which has also boosted shares of partner ClearPoint Neuro Inc.

ClearPoint Neuro reported total operating expenses of $11.3 million in the quarter. The company ended the period with $12.4 million in cash and cash equivalents. “Our 2025 fiscal year is off to a ...

Clearpoint Agency, a San Diego-based public relations agency with offices in Carlsbad and Boston, has promoted Hilary McCarthy from public relations and content manager to vice president. Clearpoint ...